US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.01

-0.1100-0.99%

Post-market: 11.010.00000.00%16:15 EDT

Volume:390.33K

Turnover:4.29M

Market Cap:3.73B

PE:115.43

High:11.10

Open:11.08

Low:10.93

Close:11.12

52wk High:13.11

52wk Low:6.28

Shares:339.00M

Float Shares:272.00M

Volume Ratio:1.09

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0954

EPS(LYR):-0.0211

ROE:7.36%

ROA:2.71%

PB:7.65

PE(LYR):-521.80

Loading ...

Overview Company News Filings

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Regeneron Deal And Phase 3 IPAX BrIGHT Launch

Simply Wall St.

Telix Pharmaceuticals Becomes Most Shorted ASX Stock as of April 15, ASIC Data Shows

MT Newswires Live

Telix Sets Hybrid 2026 AGM to Engage Global Investor Base

Telix raises US$600m via new convertible notes to refinance 2029 bonds

Telix Pharmaceuticals Says JPMorgan Increases Stake

MT Newswires Live

Canaccord Genuity Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)

Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme

Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)

Telix Pharmaceuticals Doses First Patient in Phase 3 Brain Cancer Trial

MT Newswires Live

Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Top Premarket Decliners

MT Newswires Live

Telix Refinances Convertible Bonds

Telix Showcases Glioblastoma Case Response and Details Offshore Convertible Bond Offer

Telix Raises US$550m in Convertible Note Refi to Extend Debt Maturity

Telix Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push

Telix and Regeneron Announce Strategic Radiopharma Collaboration

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TLX/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":11.01,"timestamp":1791489600000,"preClose":11.12,"halted":0,"volume":390334,"hourTrading":{"tag":"盘后","latestPrice":11.01,"preClose":11.01,"latestTime":"16:15 EDT","volume":111,"amount":1222.11,"timestamp":1791490500237,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0098920863309352,"floatShares":272000000,"shares":339000000,"eps":0.095386,"marketStatus":"Post-Mkt","change":-0.11,"latestTime":"10-08 18:32:23 EDT","open":11.08,"high":11.1,"low":10.93,"amount":4292525,"amplitude":0.015288,"askPrice":11.25,"askSize":5,"bidPrice":10.4,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.095386,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":11.12,"preHourTrading":{"tag":"盘前","latestPrice":11,"preClose":11.12,"latestTime":"07:11 EDT","volume":174,"amount":1888.419912,"timestamp":1791457917068,"change":-0.12,"changeRate":-0.010791,"amplitude":0.036871},"postHourTrading":{"tag":"盘后","latestPrice":11.01,"preClose":11.01,"latestTime":"16:15 EDT","volume":111,"amount":1222.11,"timestamp":1791490500237,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.090779},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":272000000,"roa":"2.71%","roe":"7.36%","lyrEps":-0.0211,"volumeRatio":1.090779,"shares":339000000,"dividePrice":0,"high":11.1,"amplitude":0.015288,"preClose":11.12,"low":10.93,"week52Low":6.28,"pbRate":"7.65","psRate":"4.19","week52High":13.1098,"institutionHeld":0,"latestPrice":11.01,"eps":0.095386,"divideRate":0,"volume":390334,"delay":0,"ttmEps":0.095386,"open":11.08,"prevYearClose":7.49,"prevWeekClose":10.55,"prevMonthClose":10.97,"prevQuarterClose":10.97,"fiveDayClose":10.72,"twentyDayClose":11.9,"sixtyDayClose":11.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"TLX","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1758254400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2026-10-07","current":116.578953,"percent":0.27907,"low":-584.49693,"twenty":-429.411057,"median":169.604202,"eighty":241.190668,"high":383.853933,"avg":28.330875,"sd":304.807262,"marketCap":3753307402.38},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-08","current":119.575098,"twenty":163.364827,"median":173.121803,"eighty":185.031841,"marketCap":3879545892.37},{"date":"2025-08-15","current":118.626089,"twenty":162.985468,"median":172.816584,"eighty":184.520886,"marketCap":3844757658.1},{"date":"2025-08-22","current":367.342977,"twenty":162.565192,"median":172.783145,"eighty":185.031841,"marketCap":3983594342.69},{"date":"2025-08-29","current":297.28853,"twenty":162.917681,"median":173.086118,"eighty":186.439488,"marketCap":3223899680.91},{"date":"2025-09-05","current":280.194275,"twenty":162.97191,"median":173.155042,"eighty":187.353158,"marketCap":3038523660.62},{"date":"2025-09-12","current":284.24913,"twenty":163.053254,"median":173.392729,"eighty":189.722035,"marketCap":3082495919.22},{"date":"2025-09-19","current":299.993591,"twenty":163.181765,"median":173.840405,"eighty":192.411646,"marketCap":3253234303.96},{"date":"2025-09-26","current":303.368871,"twenty":163.269039,"median":174.34097,"eighty":195.332201,"marketCap":3289837005.56},{"date":"2025-10-03","current":316.222238,"twenty":163.331056,"median":174.844246,"eighty":197.182743,"marketCap":3429223360.77},{"date":"2025-10-10","current":308.943311,"twenty":163.584606,"median":175.579785,"eighty":198.432664,"marketCap":3350288154.24},{"date":"2025-10-17","current":337.724829,"twenty":164.112905,"median":175.99796,"eighty":200.117317,"marketCap":3662404902.51},{"date":"2025-10-24","current":335.676999,"twenty":164.422238,"median":176.508379,"eighty":204.373856,"marketCap":3640197520.67},{"date":"2025-10-31","current":328.898919,"twenty":164.871944,"median":177.318176,"eighty":280.077091,"marketCap":3566693671.28},{"date":"2025-11-07","current":302.845362,"twenty":165.230483,"median":178.059203,"eighty":285.744085,"marketCap":3284159889.46},{"date":"2025-11-14","current":289.051675,"twenty":165.371547,"median":178.295984,"eighty":290.299055,"marketCap":3134576370.19},{"date":"2025-11-21","current":278.19044,"twenty":165.561349,"median":179.014446,"eighty":289.541689,"marketCap":3016793389.39},{"date":"2025-11-28","current":310.533522,"twenty":165.669807,"median":179.412236,"eighty":291.060611,"marketCap":3367532955.32},{"date":"2025-12-05","current":306.208941,"twenty":165.670741,"median":180.00406,"eighty":294.691227,"marketCap":3320635708.33},{"date":"2025-12-12","current":286.055209,"twenty":165.873166,"median":180.584513,"eighty":295.905706,"marketCap":3102081667.78},{"date":"2025-12-19","current":244.707348,"twenty":165.940952,"median":181.091444,"eighty":294.691227,"marketCap":2653691145.03},{"date":"2025-12-26","current":248.848958,"twenty":166.394684,"median":181.60348,"eighty":294.390689,"marketCap":2698604201.29},{"date":"2026-01-02","current":236.757004,"twenty":166.574536,"median":182.507221,"eighty":293.840477,"marketCap":2567474872.89},{"date":"2026-01-09","current":234.880062,"twenty":166.797362,"median":182.734458,"eighty":292.111558,"marketCap":2547120662.92},{"date":"2026-01-16","current":240.619616,"twenty":166.998047,"median":183.212494,"eighty":291.104403,"marketCap":2609362374.53},{"date":"2026-01-23","current":233.793317,"twenty":167.188576,"median":183.578507,"eighty":290.823686,"marketCap":2535335622.99},{"date":"2026-01-30","current":230.611959,"twenty":167.428163,"median":183.988776,"eighty":290.419247,"marketCap":2500835870.83},{"date":"2026-02-06","current":214.320895,"twenty":167.500324,"median":184.979028,"eighty":290.056234,"marketCap":2324169939.4},{"date":"2026-02-13","current":194.105832,"twenty":167.571527,"median":185.74722,"eighty":289.461299,"marketCap":2104950801.53},{"date":"2026-02-20","current":-349.931165,"twenty":167.550165,"median":186.245055,"eighty":289.186438,"marketCap":2493259551.93},{"date":"2026-02-27","current":-337.576812,"twenty":166.94361,"median":185.358176,"eighty":288.884688,"marketCap":2405234781.68},{"date":"2026-03-06","current":-357.014534,"twenty":165.886723,"median":184.229774,"eighty":287.796958,"marketCap":2543728559.75},{"date":"2026-03-13","current":-380.87359,"twenty":165.371547,"median":183.661424,"eighty":286.105301,"marketCap":2713724328.68},{"date":"2026-03-20","current":-427.441295,"twenty":164.112905,"median":183.427298,"eighty":285.888656,"marketCap":3045519229.47},{"date":"2026-03-27","current":-448.04178,"twenty":163.181765,"median":182.800475,"eighty":285.212188,"marketCap":3192297684.03},{"date":"2026-04-02","current":-425.435204,"twenty":162.890567,"median":182.629922,"eighty":285.17117,"marketCap":3031225831.43},{"date":"2026-04-10","current":-492.382264,"twenty":161.467054,"median":181.810223,"eighty":284.24913,"marketCap":3508223631.57},{"date":"2026-04-17","current":-499.465833,"twenty":158.955031,"median":181.091444,"eighty":284.07528,"marketCap":3558694058.36},{"date":"2026-04-24","current":-507.89561,"twenty":156.233199,"median":180.584513,"eighty":282.031139,"marketCap":3618756217.23},{"date":"2026-05-01","current":-532.518745,"twenty":154.872282,"median":180.00406,"eighty":281.147736,"marketCap":3794196059.21},{"date":"2026-05-08","current":-508.824558,"twenty":144.045965,"median":179.412236,"eighty":280.966174,"marketCap":3625374971.37},{"date":"2026-05-15","current":-506.065728,"twenty":140.182144,"median":178.86094,"eighty":280.209239,"marketCap":3605718311.9},{"date":"2026-05-22","current":-452.537308,"twenty":125.947014,"median":178.262158,"eighty":280.194275,"marketCap":3224328322.29},{"date":"2026-05-29","current":-444.681415,"twenty":120.122064,"median":178.059203,"eighty":279.725537,"marketCap":3168355079.47},{"date":"2026-06-05","current":-452.683664,"twenty":115.968865,"median":177.318176,"eighty":279.589795,"marketCap":3225371110.32},{"date":"2026-06-12","current":-453.131496,"twenty":29.784924,"median":176.508379,"eighty":278.469383,"marketCap":3228561906.13},{"date":"2026-06-18","current":-479.232706,"twenty":-319.885885,"median":176.029393,"eighty":275.361846,"marketCap":3414533028.17},{"date":"2026-06-26","current":-505.22407,"twenty":-336.088027,"median":175.625224,"eighty":265.637187,"marketCap":3599721496.58},{"date":"2026-07-02","current":-567.292731,"twenty":-347.690038,"median":175.082406,"eighty":259.576863,"marketCap":4041960704.33},{"date":"2026-07-10","current":-538.02731,"twenty":-371.335373,"median":174.480785,"eighty":256.751103,"marketCap":3833444584.84},{"date":"2026-07-17","current":-497.824928,"twenty":-406.861587,"median":173.909122,"eighty":252.484997,"marketCap":3547002606.6},{"date":"2026-07-24","current":-487.362208,"twenty":-419.925535,"median":173.731386,"eighty":249.449835,"marketCap":3472455733.71},{"date":"2026-07-31","current":-475.018244,"twenty":-425.317007,"median":173.324997,"eighty":249.116107,"marketCap":3384504988.78},{"date":"2026-08-07","current":-543.110083,"twenty":-431.380818,"median":173.121803,"eighty":248.587668,"marketCap":3869659340.88},{"date":"2026-08-14","current":-563.285348,"twenty":-444.416873,"median":172.850024,"eighty":247.242146,"marketCap":4013408103.64},{"date":"2026-08-21","current":112.812357,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"marketCap":3778875522.96},{"date":"2026-08-28","current":114.191675,"twenty":-444.681415,"median":171.69944,"eighty":244.665977,"marketCap":3825078550.57},{"date":"2026-09-04","current":120.218119,"twenty":-444.416873,"median":171.125205,"eighty":244.246526,"marketCap":4026946335.18},{"date":"2026-09-11","current":113.993217,"twenty":-443.358706,"median":170.839525,"eighty":243.230652,"marketCap":3818430784.57},{"date":"2026-09-18","current":128.771395,"twenty":-438.399131,"median":170.279278,"eighty":242.301839,"marketCap":4313455406.44},{"date":"2026-09-25","current":113.11909,"twenty":-435.525335,"median":170.22876,"eighty":242.197204,"marketCap":3789150143.08},{"date":"2026-10-02","current":106.450812,"twenty":-432.365699,"median":169.774316,"eighty":242.047247,"marketCap":3565782844.39},{"date":"2026-10-07","current":112.049061,"twenty":-429.411057,"median":169.604202,"eighty":241.190668,"marketCap":3753307402.38}],"updateTime":1791456422802},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629636900","title":"ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629636900","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629636900?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:49","pubTimestamp":1776804540,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, April  22, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that safety and tolerability data from the Pro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278510/0/en/ProstACT-Global-Phase-3-Part-1-Selected-as-Late-Breaking-Abstract-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BK4139","BK4141","BK4526","ASX","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629070229","title":"Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Regeneron Deal And Phase 3 IPAX BrIGHT Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629070229","media":"Simply Wall St.","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629070229?lang=en_us&edition=fundamental","pubTime":"2026-04-21 10:10","pubTimestamp":1776737430,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) has drawn fresh investor attention after Regeneron agreed to a US$40 million upfront payment to access its radiopharmaceutical platform, alongside Telix starting the pivotal Phase 3 IPAX BrIGHT trial in recurrent glioblastoma.\nSee our latest analysis for Telix Pharmaceuticals.\nAgainst this backdrop, Telix’s recent news is landing on a share price that has gained 15.76% over the past 30 days and 28.46% over 90 days, while the 1 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/assessing-telix-pharmaceuticals-asxtlx-valuation-after-regen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/assessing-telix-pharmaceuticals-asxtlx-valuation-after-regen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","TLX","BK4139","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629703479","title":"Telix Pharmaceuticals Becomes Most Shorted ASX Stock as of April 15, ASIC Data Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2629703479","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629703479?lang=en_us&edition=fundamental","pubTime":"2026-04-21 09:55","pubTimestamp":1776736508,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  was the most shorted stock on the Australian Securities Exchange as of April 15 with 16.51% short positions, taking the place of Domino's Pizza Enterprises , according to data from the Australian Securities & Investments Commission.Domino's Pizza is now the second most shorted stock with 15.44% short positions, data showed.Telix Pharmaceuticals' shares fell 2% in recent Tuesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4141","BK4512","LU1861214812.USD","IE00BD6J9T35.USD","ASIC","IE00BZ199S13.USD","LU0124384867.USD","LU1861215975.USD","BK4605","LU1720051108.HKD","DMP.AU","LU2360107325.USD","LU1861220033.SGD","LU0724618433.USD","ON","TLX.AU","BK7137","LU1548497426.USD","LU1854103824.USD","BK4585","BK4139","LU0348723411.USD","BK4588","LU1854104046.USD","LU2298322129.HKD","LU1861219969.SGD","LU1978683503.SGD","BK4107","BK7067","TLX","LU2357305700.SGD","IE00BFMHRM44.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629177476","title":"Telix Sets Hybrid 2026 AGM to Engage Global Investor Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2629177476","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629177476?lang=en_us&edition=fundamental","pubTime":"2026-04-21 06:44","pubTimestamp":1776725084,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an update. Telix Pharmaceuticals has scheduled its 2026 Annual General Meeting for May 21 in Melb...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-sets-hybrid-2026-agm-to-engage-global-investor-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-sets-hybrid-2026-agm-to-engage-global-investor-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4229","BK4139","AGM","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628717538","title":"Telix raises US$600m via new convertible notes to refinance 2029 bonds","url":"https://stock-news.laohu8.com/highlight/detail?id=2628717538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628717538?lang=en_us&edition=fundamental","pubTime":"2026-04-20 15:19","pubTimestamp":1776669553,"startTime":"0","endTime":"0","summary":"An announcement from Telix Pharmaceuticals ( ($AU:TLX) ) is now available. Telix Pharmaceuticals has detailed the issuance of US$600 million in 1.5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-raises-us600m-via-new-convertible-notes-to-refinance-2029-bonds?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-raises-us600m-via-new-convertible-notes-to-refinance-2029-bonds?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628606227","title":"Telix Pharmaceuticals Says JPMorgan Increases Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2628606227","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628606227?lang=en_us&edition=fundamental","pubTime":"2026-04-17 13:35","pubTimestamp":1776404146,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) said JPMorgan Chase & Co. and its affiliates have increased their stake in the company on Tuesday to 11.5% or 39 million shares from 7.7% or 26.1 million shares, according to a Friday Australian bourse filing.The company's shares fell past 2% in recent Friday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0211326839.USD","IE00BDRTCR15.USD","LU1548497426.USD","LU2023250504.SGD","LU0211327993.USD","LU1917777945.USD","JPO","LU2756315318.SGD","LU0211328371.USD","LU0251132253.USD","LU0310799852.SGD","LU0964807845.USD","LU1116320901.HKD","LU2213496289.HKD","TLX.AU","LU0859254822.USD","LU1084165304.USD","LU2756315664.SGD","LU2746668461.USD","LU1670628061.USD","BK4139","LU0417517546.SGD","LU0868494617.USD","LU2264538146.SGD","LU2430703251.USD","BK7067","LU2552382132.HKD","LU0345769631.USD","LU1668664300.SGD","LU0265550359.USD","LU0345770993.USD","LU0942090050.USD","LU2237443549.SGD","IE00BWXC8680.SGD","LU2237443382.USD","LU1720051017.SGD","LU2023250843.SGD","LU0203345920.USD","IE00BYXW3230.USD","JPMO","LU0215105999.USD","IE0034235303.USD","IE00BLSP4239.USD","LU0106261372.USD","LU2242649171.HKD","BK4550","TLX","BK4585","IE00BJTD4N35.SGD","LU1116320737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628819240","title":"Canaccord Genuity Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2628819240","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628819240?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:38","pubTimestamp":1776382695,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Shane Storey maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$30.00. Storey covers the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPPF","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627073260","title":"Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2627073260","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627073260?lang=en_us&edition=fundamental","pubTime":"2026-04-16 16:13","pubTimestamp":1776327200,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has notified the market of the issue of new unquoted share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-issues-new-unquoted-share-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-issues-new-unquoted-share-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284519","title":"Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284519?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:21","pubTimestamp":1776255689,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbCellera Biologics (ABCL), Telix Pharmaceuticals (T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abcellera-biologics-abcl-telix-pharmaceuticals-othertlppf-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abcellera-biologics-abcl-telix-pharmaceuticals-othertlppf-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2592432038.USD","IE00B19Z3581.USD","JNJ","IE000SO60NU8.SGD","IE00BJT1NW94.SGD","LU1061106388.HKD","IE000F7OJYX1.SGD","LU2347655156.SGD","LU2505996681.GBP","LU0882574055.USD","LU1267930813.SGD","XBI","LU1057294990.SGD","LU1244550494.USD","LU0345769631.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU1043141396.HKD","BK4559","SG9999002224.SGD","IE00BLSP4452.SGD","LU0234570918.USD","LU1261432733.SGD","BK4533","LU1935042991.SGD","IE000BZT7R73.USD","LU2129689514.USD","LABU","BK4568","LU1066051498.USD","LU1221951046.USD","TLX","LU1244550221.USD","LU1718418525.SGD","XLV","LU0098860793.USD","IE00BFXG1179.USD","LU0203345920.USD","LU0683600562.USD","LU0889566641.SGD","ABCL","IE00BJJMRZ35.SGD","LU0029874061.USD","LU2471134952.CNY","LU0426412945.USD","HCSG","LU2468319806.SGD","IE00B4R5TH58.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627400631","title":"Telix Pharmaceuticals Doses First Patient in Phase 3 Brain Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627400631","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627400631?lang=en_us&edition=fundamental","pubTime":"2026-04-15 17:30","pubTimestamp":1776245418,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (TLX) said Wednesday it dosed the initial patient in a Phase 3 clinical trial evaluating its radiopharmaceutical therapy for recurrent glioblastoma, a type of brain cancer.The gl","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","BK7067","TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627478475","title":"Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2627478475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627478475?lang=en_us&edition=fundamental","pubTime":"2026-04-15 07:48","pubTimestamp":1776210514,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has shared an update. Telix Pharmaceuticals has lodged an Appendix 3B with the ASX outlining a proposed issue o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-files-appendix-3b-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-files-appendix-3b-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627203064","title":"Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627203064","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627203064?lang=en_us&edition=fundamental","pubTime":"2026-04-15 06:50","pubTimestamp":1776207000,"startTime":"0","endTime":"0","summary":"The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHTis assessing the safety and efficacy of TLX101-Tx in combination with chemotherapy , compared to chemotherapy alone. The global, multicenter, open-label study will enroll patients with radiographically confirmed recurrent glioblastoma at first recurrence.IPAX BrIGHT expands upon promising data from earlier trials in the recurrent glioblastoma setting, includingIPAX-1[3], which reported a median overall survival  of 13 months from the initiation of treatment with TLX101-Tx, or 23 months from initial diagnosis[4]. Preliminary results from the IPAX-Linz investigator-initiated trial of TLX101-Tx were consistent and confirmatory to IPAX-1, with a median OS of12.4 monthsfrom initiation of treatment and32.2 monthsfrom initial diagnosis[5]. Beyond the clinical trial setting, an early access program for TLX101-Tx in Europe has dosed 18 patients at first recurrence or later, fur","market":"us","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-doses-first-patient-in-phase-3-ipax-bright-trial-of-tlx101-tx-for-recurrent-glioblastoma-302742412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","BK7067","XKO.AU","BK4543","ASX","SEC.AU","XJO.AU","GBM.AU","TLX.AU","XAO.AU","TLX","BK7039","BK4141","BK4526","ASX.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445663","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445663?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:01","pubTimestamp":1776168074,"startTime":"0","endTime":"0","summary":"T1 Energy  shares were 5.7% lower in Tuesday's premarket activity after the company said it is proposing an underwritten public offering of $125 million in convertible senior notes due 2031.CarMax  shares were down 4.2% after the company reported lower fiscal Q4 adjusted earnings and net sales and operating revenue from a year earlier.Telix Pharmaceuticals  stock was 5.1% lower after the company said it commenced a $550 million offering of convertible notes due 2031.Wells Fargo  shares were down 2.4% after the Wall Street bank reported lower-than-expected Q1 revenue.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1035773651.USD","LU0314106906.USD","LU1506573853.SGD","BK4139","LU0175139822.USD","LU2236285917.USD","IE000M9KFDE8.USD","KMX","LU0787776722.HKD","LU2361044865.SGD","LU0251131958.USD","LU0106831901.USD","IE00B7SZLL34.SGD","LU1267930227.SGD","LU0477156953.USD","LU0310799852.SGD","LU1267930573.SGD","LU0683600562.USD","LU1791807156.HKD","TLX","LU0971096721.USD","LU1074936037.SGD","LU0208291251.USD","LU0029864427.USD","LU1668664300.SGD","IE00B19Z3B42.SGD","LU0048573561.USD","IE0002270589.USD","LU1363072403.SGD","BK4207","LU0211327993.USD","LU1069347547.HKD","LU0942090050.USD","BK4559","LU0640476718.USD","BK4096","LU1814569148.SGD","LU0149725797.USD","BK4588","LU0154236417.USD","LU0130102774.USD","LU0417517546.SGD","LU1894683348.USD","TE","LU0251142724.SGD","BK4504","LU0310800379.SGD","LU2361045086.USD","TLX.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627416002","title":"Telix Refinances Convertible Bonds","url":"https://stock-news.laohu8.com/highlight/detail?id=2627416002","media":"prnewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627416002?lang=en_us&edition=fundamental","pubTime":"2026-04-14 16:32","pubTimestamp":1776155520,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited   today launches an offering of US$550 million convertible notes due 2031 to be issued by its wholly-owned subsidiary, Telix Pharmaceuticals  Inc. , and guaranteed by Telix and Telix Pharmaceuticals  Inc. . The convertible notes, also referred to as \"convertible bonds\" , are convertible into fully paid ordinary shares in Telix .Managing Director and Group CEO, Dr. Christian Behrenbruch, said: \"The refinance of the existing Convertible Bonds represents our proactive approach to capital management. The new Convertible Bonds will continue to provide the business with cost effective financing.\". The new Convertible Bonds represent attractive, low-cost financing to Telix and are non-dilutive until any potential future conversions occur. The initial conversion price will be at a premium to Telix's current share price.After deduction of commissions, professional fees and other administrat","market":"sg","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-refinances-convertible-bonds-302741509.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","BK4543","ASX","TLX.AU","BK7067","BK4526","BK4139","SEC.AU","ASX.AU","TLX","BK7039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627619415","title":"Telix Showcases Glioblastoma Case Response and Details Offshore Convertible Bond Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627619415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627619415?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:53","pubTimestamp":1776153223,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an update. Telix Pharmaceuticals has highlighted clinical imaging data showing a patient with rec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-showcases-glioblastoma-case-response-and-details-offshore-convertible-bond-offer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-showcases-glioblastoma-case-response-and-details-offshore-convertible-bond-offer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US10Y.BOND","TLX","US2Y.BOND","US5Y.BOND","TLTW","TMF","US7Y.BOND","TLT","BK4139","US12M.BOND","US3Y.BOND","US6M.BOND","US30Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627418997","title":"Telix Raises US$550m in Convertible Note Refi to Extend Debt Maturity","url":"https://stock-news.laohu8.com/highlight/detail?id=2627418997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627418997?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:11","pubTimestamp":1776150670,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has launched a US$550 million offering of five‑year ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-raises-us550m-in-convertible-note-refi-to-extend-debt-maturity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-raises-us550m-in-convertible-note-refi-to-extend-debt-maturity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432787","title":"Telix Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432787","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432787?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:12","pubTimestamp":1776078720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 13, 2026 07:12 ET (11:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627101146","title":"Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2627101146","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627101146?lang=en_us&edition=fundamental","pubTime":"2026-04-13 06:59","pubTimestamp":1776034766,"startTime":"0","endTime":"0","summary":"An announcement from Telix Pharmaceuticals ( ($AU:TLX) ) is now available. Telix Pharmaceuticals and Regeneron Pharmaceuticals have entered a strat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-and-regeneron-strike-global-radiopharma-alliance-in-precision-oncology-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-and-regeneron-strike-global-radiopharma-alliance-in-precision-oncology-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627101920","title":"Telix and Regeneron Announce Strategic Radiopharma Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2627101920","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627101920?lang=en_us&edition=fundamental","pubTime":"2026-04-13 06:57","pubTimestamp":1776034620,"startTime":"0","endTime":"0","summary":"Telix to receive US$40 million upfront for four initial programs with optionality on a per program basis to co-fund commercialization and profit-share or earnup to an aggregate of US$2.1 billion in developmentand commercial milestone payments pluslow double-digit royalties.","market":"sh","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-and-regeneron-announce-strategic-radiopharma-collaboration-302739967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1974910355.USD","LU2362541273.HKD","BK4588","LU0114720955.EUR","TLX.AU","BK7067","TLX","LU2023250504.SGD","LU0823434740.USD","REGN","LU0823416689.USD","BK4543","LU2468319806.SGD","LU0109394709.USD","LU0882574055.USD","LU1917777945.USD","BK4526","LU2237438978.USD","BK4139","BK4585","BK7039","LU0053666078.USD","SEC.AU","LU2089984988.USD","LU0889565916.HKD","ASX.AU","ASX","LU2362541513.USD","LU0320765992.SGD","LU0823434583.USD","BK4141","LU2106854487.HKD","LU2362540622.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":199,"code":"91000000","status":"200"}]}}